Abstract:Objective: To analyse the mechanism of invasion and metastasis of hepatocellular carcinoma by MST based on the MAPK-ERK signalling pathway. Methods: Human hepatoma cell lines were cultured in vitro and cells that were grown in logarithm were divided into a control group (8 cells, no treatment), a high expression group (8 cells, treatment with high expression of MST4 transfection), and a low expression group (8 cells, treatment with low expression of MST4 transfection). Real-time quantitative PCR was used to detect the expression of the inflammatory factors present in each group of hepatoma cells; MTT assay was used to detect the proliferation of cells in each group; Transwell assay was used to detect the invasion and migration ability of each group; Western blot was used to detect the expression of ERK, p-ERK protein; and ELISA was used to detect changes in the inflammatory factor levels in each group of rats. Results: The real-time quantitative PCR results showed that the transcription levels of IL-6, IL-1 beta, TNF-alpha, and CCL-2 in high expression group of MST4 cells were significantly higher than those in the control group and the low expression group, and the difference was statistically significant (P<0.01); the MTT assay showed that the absorbance of hepatocarcinoma cells in the high expression group was also found to be significantly higher than both the control group and the low expression group, with the difference being statistically significant (P<0.01). Transwell test results showed that the number of invasion and migration of hepatocarcinoma cells in the high expression group was also significantly higher than that of the control group and the low expression group, with the difference being statistically significant (P<0.01). The results of the Western blot showed that there was no significant difference in the expression of ERK protein between the three groups (P>0.05). Furthermore, it was found that the expression of p-ERK protein in the high expression group of MST4 was significantly higher than that of the control group and low expression group, and the difference was statistically significant (P<0.01). The secretion of IL-6, IL-1 beta, TNF-alpha, CCL-2 of liver cancer cells in high expression group was also significantly higher than that of the control group and the ERK inhibitor group (P<0.01), which indicated that ERK inhibitors can significantly inhibit the secretion of inflammatory factors by liver cancer cells. Conclusion: MST4 can promote tumour secretion of inflammatory factors and enhance the invasion and metastasis ability of liver cancer cells through a MAPK-ERK signalling pathway.

Methionine Sulfoxide Reductase B1 Regulates Hepatocellular Carcinoma Cell Proliferation and Invasion Via the Mitogen-Activated Protein Kinase Pathway and Epithelial-Mesenchymal Transition

Methionine sulfoxide reductase B1 regulates proliferation and invasion by affecting mitogen-activated protein kinase pathway and epithelial-mesenchymal transition in u2os cells.

MNS1 Promotes Hepatocarcinogenesis and Metastasis Via Activating PI3K/AKT by Translocating Β‐catenin and Predicts Poor Prognosis

MsrB1 Promotes Proliferation and Invasion of Colorectal Cancer Cells Via GSK-3β/β-catenin Signaling Axis

SIRT1 Facilitates Hepatocellular Carcinoma Metastasis by Promoting PGC-1α-mediated Mitochondrial Biogenesis.

Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma.

Mir-424-3p Promotes Metastasis of Hepatocellular Carcinoma Via Targeting the SRF-STAT1/2 Axis.

Mineralocorticoid Receptor Suppresses Cancer Progression and the Warburg Effect by Modulating the Mir-338-3p-Pklr Axis in Hepatocellular Carcinoma

MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma

SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling

MicroRNA-6838-5p Suppresses the Self-Renewal and Metastasis of Human Liver Cancer Stem Cells Through Downregulating CBX4 Expression and Inactivating ERK Signaling

Synergistic Effect of MC-LR and C-Terminal Truncated HBx on HepG2 Cells and Their Effects on PP2A Mediated Downstream Target of MAPK Signaling Pathway

Study on invasion and metastasis of hepatocellular carcinoma by mst based on mapk-erk signaling pathway

Methylation-regulated Mir-124-1 Suppresses Tumorigenesis in Hepatocellular Carcinoma by Targeting CASC3

Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells

SULT2B1b Promotes Epithelial-Mesenchymal Transition Through Activation of the Β-Catenin/mmp7 Pathway in Hepatocytes

Mir-184 Post-Transcriptionally Regulates SOX7 Expression and Promotes Cell Proliferation in Human Hepatocellular Carcinoma

Breast Cancer Metastasis Suppressor 1 Regulates Hepatocellular Carcinoma Cell Apoptosis Via Suppressing Osteopontin Expression

Sulfiredoxin-1 promotes the growth of hepatocellular carcinoma by inhibiting TFEB-mediated autophagy and lysosome biogenesis

3‐Mercaptopyruvate sulfurtransferase represses tumour progression and predicts prognosis in hepatocellular carcinoma

MST4 Promotes Hepatocellular Carcinoma Epithelial-Mesenchymal Transition and Metastasis Via Activation of the P-Erk Pathway.